Ventricular Lavage for Post-Haemorrhagic Hydrocephalus
Author Information
Author(s): Ian Pople, Andrew Whitelaw
Primary Institution: Department of Neurosurgery, Frenchay Hospital, Bristol, UK; Department of Neonatal Medicine, Southmead Hospital, Bristol, UK
Hypothesis
Does DRIFT treatment provide better outcomes than standard treatment for preterm infants with PHVD?
Conclusion
DRIFT treatment reduced severe cognitive disability in survivors and overall rates of death or severe disability despite an increased rate of secondary intraventricular bleeding.
Supporting Evidence
- 54% of infants in the DRIFT group died or were severely disabled compared to 71% in the standard group.
- 31% of survivors in the DRIFT group had severe cognitive disability compared to 59% in the standard group.
- The median Mental Development Index was 68 for DRIFT and 50 for standard care.
Takeaway
The study looked at a new treatment for babies with brain swelling and found it helped some babies do better, even though it caused some extra bleeding.
Methodology
77 preterm infants with PHVD were randomly allocated to either DRIFT or standard treatment, and severe disability was assessed at 2 years’ corrected age.
Potential Biases
Potential bias in random allocation and assessment of outcomes.
Limitations
The study did not assess long-term outcomes beyond 2 years.
Participant Demographics
Preterm infants with post-ventricular dilatation.
Statistical Information
Confidence Interval
0.08–0.82
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website